|
|
![]() |
![]() |
![]() |
![]() |
|
![]() |
|
![]() |
|
![]() |
|
![]() |
![]() |
![]() |
|
![]() |
|||||||||||||||||||||||||||||||||||||||||||||
| Sponsors and Collaborators: |
M.D. Anderson Cancer Center National Cancer Institute (NCI) |
| Information provided by: | M.D. Anderson Cancer Center |
| ClinicalTrials.gov Identifier: | NCT00490282 |
Purpose
Primary Objective:
1. To demonstrate improved normal tissue sparing dosimetry with head and neck (H&N) adaptive radiotherapy (ART) planning relative to standard intensity-modulated radiation therapy (IMRT) planning in 30 locally advanced oropharyngeal cancer patients.
Secondary Objectives:
| Condition | Intervention |
|
Head and Neck Cancer Oropharyngeal Cancer |
Radiation: Intensity Modulated Radiation Therapy Radiation: Adaptive Radiotherapy |
| MedlinePlus related topics: | Cancer Head and Neck Cancer Nuclear Scans |
| Study Type: | Interventional |
| Study Design: | Diagnostic, Non-Randomized, Open Label, Uncontrolled, Single Group Assignment |
| Official Title: | A Pilot Trial of Image-Guided Adaptive Radiotherapy for Head and Neck Cancer |
| Estimated Enrollment: | 30 |
| Study Start Date: | June 2007 |
| Estimated Primary Completion Date: | June 2009 (Final data collection date for primary outcome measure) |
| Arms | Assigned Interventions |
|
1: Experimental
Intensity Modulated Radiotherapy + Adaptive Radiotherapy
|
Radiation: Intensity Modulated Radiation Therapy
IMRT Treatment Over 6-7 Weeks
Radiation: Adaptive Radiotherapy
ART Treatment Over 6-7 Weeks
|
![]() |
Show Detailed Description |
Eligibility
| Ages Eligible for Study: | 18 Years and older |
| Genders Eligible for Study: | Both |
| Accepts Healthy Volunteers: | No |
Inclusion Criteria:
Exclusion:
Contacts and Locations| Contact: David Schwartz, MD | 713-562-2300 |
| United States, Texas | |||||
| U.T.M.D. Anderson Cancer Center | Recruiting | ||||
| Houston, Texas, United States, 77030 | |||||
| Principal Investigator: David Schwartz, MD | |||||
| M.D. Anderson Cancer Center |
| National Cancer Institute (NCI) |
| Principal Investigator: | David Schwartz, MD | U.T.M.D. Anderson Cancer Center |
More Information
Related Info 
  |
| Responsible Party: | U.T.M.D. Anderson Cancer Center ( David Schwartz, MD/Assistant Professor ) |
| Study ID Numbers: | 2006-0947 |
| First Received: | June 21, 2007 |
| Last Updated: | September 25, 2008 |
| ClinicalTrials.gov Identifier: | NCT00490282 |
| Health Authority: | United States: Institutional Review Board |
|
|
|
|
|